AI-generated summary
The authors reviewed pre-clinical and clinical studies of photobiomodulation with red and near-infrared light for major depressive disorder, including 17 original studies from MEDLINE and EMBASE searches. They report that animal studies showed benefit comparable to antidepressant medications and that clinical studies indicated a significant antidepressant effect with good tolerability. The authors note that clinical studies were heterogeneous and most lacked an appropriate control, so they describe the evidence as preliminary.
- Studies included
- 17
- Who or what was studied
- Patients with major depressive disorder in clinical studies, and animal models in pre-clinical studies
- Limits stated in the abstract
- Clinical studies are heterogeneous for population and treatment parameters, and most lack an appropriate control.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Near-infrared, Cytochrome c oxidase. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.